The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Esmail M Al-EzziAmer ZahralliyaliAaron R HansenRobert J HamiltonMichael CrumpJohn KuruvillaLori A WoodLucia NappiChristian K KollmannsbergerScott A NorthEric WinquistDenis SoulieresSebastien J HotteDi Maria JiangPublished in: Current oncology (Toronto, Ont.) (2023)
HDCT is the most commonly used GCT salvage strategy in Canada. Significant differences exist in the treatment availability, selection, and delivery of HDCT, highlighting the need for standardization of care for patients with relapsed testicular GCT.